Abstract: An ophthalmic composition comprising Indigo Carmine, or Indigo Carmine and Trypan Blue, for identification of intraocular structures and membranes within the eye, and methods of delivering and using the same, for surgical treatments of the eye, including glaucoma and cataract surgery.

Abstract: The present invention relates to the field of viral infection therapeutic treatments and prophylactic treatments. In particular, provided are methods of treating or preventing viral infections, such as viral infections resulting from entering or infecting a subject via association with or binding to an ACE2 receptor in the subject, with ophthalmic composition, inhalation compositions, and/or topical compositions. In particular, provided are methods of treating or preventing viral infections, such as coronavirus infections, for example COVID-19 infections, in a subject exposed to, or prior to exposure to a coronavirus, for example a COVID-19, by administering an ophthalmic composition, an inhalation composition, and/or a topical composition.

Abstract: An ophthalmic composition comprising Indigo Carmine, or Indigo Carmine and Trypan Blue, for identification of intraocular structures and membranes within the eye, and methods of delivering and using the same, for surgical treatments of the eye, including glaucoma and cataract surgery.

Abstract: An intraocular lens configured to reduce or eliminate oblique incident light photic disturbances in the eye, said lens comprising anterior and posterior surfaces defining a central lens optic extending from said anterior to said posterior surfaces and a peripheral portion outside of the central lens optic, wherein the peripheral portion is a prismatic lens which redirects oblique incident light on the peripheral portion forward of the nasal retina in the eye and onto the ciliary body/pars plana region.

Abstract: An ophthalmic composition comprising Indigo Carmine, or Indigo Carmine and Trypan Blue, for identification of intraocular structures and membranes within the eye, and methods of delivering and using the same, for surgical treatments of the eye, including glaucoma and cataract surgery.

Abstract: A pharmaceutical composition comprising a muscarinic antagonist and an adenosine antagonist for topical or ophthalmic application, and ophthalmic devices containing or delivering the same, and methods of using the same, for controlling and/or reducing the progression of myopia.

Abstract: An intraocular lens configured to reduce or eliminate oblique incident light photic disturbances in the eye, said lens comprising anterior and posterior surfaces defining a central lens optic extending from said anterior to said posterior surfaces and a peripheral portion outside of the central lens optic, wherein the peripheral portion is a prismatic lens which redirects oblique incident light on the peripheral portion forward of the nasal retina in the eye and onto the ciliary body/pars plana region.

Abstract: An intraocular lens is configured to reduce or eliminate oblique incident light photic disturbances in the eye. The lens includes anterior and posterior surfaces defining a central lens optic extending from the anterior to the posterior surfaces and a peripheral portion outside of the central lens optic. The peripheral portion is a prismatic lens that redirects oblique incident light on the peripheral portion forward of the nasal retina in the eye and onto the ciliary body/pars plana region.

Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.

Abstract: Methods for the treatment of lesions originating in an epithelial layer, particularly diseases of the epithelium of the skin, bladder, oral mucosa, vagina and cervix are described. Also described are uses and formulations for the treatment of lesions originating in an epithelial layer.

Abstract: An intraocular lens is configured to reduce or eliminate oblique incident light photic disturbances in the eye. The lens includes anterior and posterior surfaces defining a central lens optic extending from the anterior to the posterior surfaces and a peripheral portion outside of the central lens optic. The peripheral portion is a prismatic lens that redirects oblique incident light on the peripheral portion forward of the nasal retina in the eye and onto the ciliary body/pars plana region.

Abstract: A device for use during an intravitreal injection procedure, the device including: a main body portion with a handle at one end for holding the device; and, a contact portion at the other end for contacting the surface of an eye; wherein the contact portion includes a distance indicator for indicating a pre-determined distance from a reference point on the eye.

Abstract: A method of maintaining the structure of an opening in the anterior or posterior capsule formed by a capsulorhexis whereby a device is inserted into opening in the anterior or posterior capsule, the device having a main body including a peripheral portion and an opening therethrough, wherein the peripheral portion engages with the inside peripheral edge of the opening in the anterior or posterior capsule, wherein the device is inserted into the opening in the anterior or posterior capsule after an intraocular lens has been inserted into the capsular bag of an eye during cataract corrective surgery.

Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.

Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.

Abstract: Compositions and methods for moulding corneal tissue in a patient for correcting or improving refractive errors in the eye, and in particular, compositions and methods for sequentially softening then hardening the corneal tissue, preferably by manipulation of matrix metalloproteinase activity in the cornea.

Abstract: Methods for the treatment of ocular lesions, particularly diseases of the surface of the eye, selected from pterygium, pinguecula, ocular dysplasia, ocular neoplastic disorders including malignancy of the limbus and eyelids in humans and animals, neurotrophic keratitis, fibrosis of conjunctival drainage blebs in glaucoma and viral disorders of the eye surface are described. Also described are uses and eyedrop formulations for the treatment of eye surface lesions.

Abstract: Methods for the treatment of lesions originating in an epithelial layer, particularly diseases of the epithelium of the skin, bladder, oral mucosa, vagina and cervix are described. Also described are uses and formulations for the treatment of lesions originating in an epithelial layer.

Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.